Inventor · disambiguated record
Jonathan Smith
Also filed as: SMITH JONATHAN · SMITH JONATHAN D · SMITH JONATHAN DREW
20 granted patents·10 pending applications·832 citations·filing 1992–2021
96Inventor score
Files withSOMALOGIC INC6CLEVELAND CLINIC FOUND5CLEVELAND CLINIC FOUNDATION3SMITH JONATHAN D3HAZEN STANLEY L2
Top patents by PatentIndex Score
30 records- 0197US6376190B1Modified SELEX processes without purified proteinSOMALOGIC INC·Filed 2000·Granted Apr 23, 2002·169 cites·9 claims
- 0294US8143224B2Oxidant resistant apolipoprotein A-1 and mimetic peptidesSMITH JONATHAN D·Filed 2008·Granted Mar 27, 2012·17 cites·18 claims
- 0393US6730482B2Modified SELEX processes without purified proteinSOMALOGIC INC·Filed 2002·Granted May 4, 2004·32 cites·5 claims
- 0493US6458539B1Photoselection of nucleic acid ligandsSOMALOGIC INC·Filed 2000·Granted Oct 1, 2002·132 cites·49 claims
- 0588US8536117B2Oxidant resistant apolipoprotein A-1 and mimetic peptidesSMITH JONATHAN D·Filed 2012·Granted Sep 17, 2013·10 cites·16 claims
- 0687US8216780B2Method for enhanced sensitivity in bacteriophage-based diagnostic assaysSMITH JONATHAN DREW·Filed 2009·Granted Jul 10, 2012·15 cites·9 claims
- 0787US6194550B1Systematic polypeptide evolution by reverse translationFiled 1998·Granted Feb 27, 2001·128 cites·9 claims
- 0886US5843701ASystematic polypeptide evolution by reverse translationNEXSTAR PHARMACETICALS INC·Filed 1992·Granted Dec 1, 1998·166 cites·40 claims
- 0985US6706482B2Conditional-selexSOMALOGIC INC·Filed 2002·Granted Mar 16, 2004·11 cites·31 claims
- 1084US9051393B2Oxidant resistant apolipoprotein A-1 and mimetic peptidesCLEVELAND CLINIC FOUNDATION·Filed 2013·Granted Jun 9, 2015·2 cites·24 claims
- 1184US8338110B2Risk markers for cardiovascular diseaseHAZEN STANLEY L·Filed 2010·Granted Dec 25, 2012·8 cites·14 claims
- 1284US6387620B1Transcription-free selexGILEAD SCIENCES INC·Filed 1999·Granted May 14, 2002·79 cites·9 claims
- 1382US8071288B2Methods and reagents for detecting target binding by nucleic acid ligandsGOLD LARRY·Filed 2008·Granted Dec 6, 2011·6 cites·34 claims
- 1478US8455186B2Method of detection of microorganisms with enhanced bacteriophage amplificationSMITH JONATHAN DREW·Filed 2008·Granted Jun 4, 2013·13 cites·2 claims
- 1578US6506887B1Conditional-selexSOMALOGIC INC·Filed 1999·Granted Jan 14, 2003·34 cites·12 claims
- 1676US7781219B2Risk markers for cardiovascular diseaseCLEVELAND CLINIC FOUNDATION·Filed 2004·Granted Aug 24, 2010·8 cites·45 claims
- 1771US9005904B2Risk markers for cardiovascular diseaseCLEVELAND CLINIC FOUNDATION·Filed 2014·Granted Apr 14, 2015·1 cites·13 claims
- 1870US8722344B2Risk markers for cardiovascular diseaseHAZEN STANLEY L·Filed 2012·Granted May 13, 2014·1 cites·9 claims
- 1970US2021270855A1Pip2 as a marker for hdl function and cardiovascular disease riskCLEVELAND CLINIC FOUND·Filed 2021·Application pending·0 cites
- 2063US2020209264A1Pip2 as a marker for hdl function and cardiovascular disease riskCLEVELAND CLINIC FOUND·Filed 2019·Application pending·0 cites
- 2162US2017336425A1Pip2 as a marker for hdl function and cardiovascular disease riskCLEVELAND CLINIC FOUND·Filed 2017·Application pending·0 cites
- 2261US9522950B2Oxidant resistant apolipoprotein A-1 and mimetic peptidesCLEVELAND CLINIC FOUND·Filed 2015·Granted Dec 20, 2016·0 cites·3 claims
- 2357US2002102599A1Transcription-free SELEXGILEAD SCIENCES·Filed 2002·Application pending·0 cites
- 2453US2006057573A1Methods and reagents for detecting target binding by nucleic acid ligandsSOMALOGIC INC·Filed 2003·Application pending·0 cites
- 2552US12292451B2ApoA1 exchange rate assays in serumCLEVELAND CLINIC FOUND·Filed 2019·Granted May 6, 2025·0 cites·9 claims
- 2646US2003054360A1Method and apparatus for the automated generation of nucleic acid ligandsFiled 2001·Application pending·0 cites
- 2746US2009286225A1Method and apparatus for bacteriophage-based diagnostic assaysMICROPHAGETM INC·Filed 2009·Application pending·0 cites
- 2844US2011183314A1Bacteriophage-based microorganism diagnostic assay using speed or acceleration of bacteriophage reproductionMICROPHAGE INC·Filed 2011·Application pending·0 cites
- 2940US2002038000A1Systematic polypeptide evolution by reverse translationFiled 2001·Application pending·0 cites
- 3035US2013158112A1Compositions and methods for inhibiting beta amyloid secretionSMITH JONATHAN D·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →